Overview
Thymosin Beta-4 is a naturally occurring 43-amino-acid protein found in most mammalian cell types and present at high concentration in platelets and wound fluid. Its principal known biological role is actin sequestration: it binds monomeric G-actin and helps regulate the equilibrium between free actin and polymerised filaments, a process central to cell motility and cytoskeletal remodelling.
TB-500 is the name commonly used in research supply for a synthetic fragment corresponding to the active region of Thymosin Beta-4. The distinction matters. Full-length Thymosin Beta-4 and the shorter synthetic fragment are related but not identical, and published studies do not always use the same material. When reading the literature it is worth confirming which was used.
Molecular characteristics
| Property | Value | | --- | --- | | Parent protein | Thymosin Beta-4, 43 residues | | Research fragment | Synthetic partial sequence | | Key functional motif | Actin-binding domain | | Typical form supplied | Lyophilized powder | | Solubility | Soluble in bacteriostatic or sterile water |
Mechanisms studied in research settings
The actin-sequestering property is the anchor for most published mechanistic work. Research groups have investigated:
- Cell migration. Because actin dynamics govern how cells move, models examining migration of endothelial cells, keratinocytes, and fibroblasts appear frequently in the literature.
- Angiogenesis models. Several studies have examined effects on endothelial tube formation in vitro.
- Inflammatory signalling. Work has looked at modulation of inflammatory mediators in animal models, though results across models are not uniform.
- Cardiac and corneal models. Thymosin Beta-4 in particular has been studied in cardiac tissue repair models and in ocular surface research.
As with other research peptides, these findings describe controlled experimental systems. They are not statements about clinical efficacy, and no approved human indication exists for the compound.
Comparing full-length protein and fragment
Researchers designing experiments should be deliberate about material selection. Published work on full-length Thymosin Beta-4 is more extensive and includes early-phase clinical investigation in specific contexts; work using the shorter synthetic fragment is largely preclinical. Conclusions drawn from one do not automatically transfer to the other, and reviewers of research work will reasonably ask which was used.
Handling and storage in the laboratory
- Keep the sealed lyophilized vial refrigerated at 2 to 8 degrees Celsius for short-term storage; minus 20 degrees Celsius or lower for longer periods.
- Reconstitute with bacteriostatic water, directing the stream against the vial wall rather than onto the powder directly, and swirl gently. Do not shake — mechanical agitation can denature peptides.
- Store reconstituted solution refrigerated, protected from light, and use within the window your protocol specifies.
- Minimise freeze-thaw cycling by aliquoting.
Evaluating supply quality
Because the research fragment is produced synthetically, purity and identity verification are essential. A batch-specific certificate of analysis should report HPLC purity at 98 percent or above and include a mass spectrometry trace confirming the expected mass. Peptide content — as distinct from purity — is also worth checking, since lyophilized material includes residual salts and water that affect the actual mass of peptide in the vial.
Research use only. This content is for educational and informational purposes related to scientific research. It is not medical advice and does not describe dosing or administration for human use. Products are sold for laboratory research by qualified professionals only.